You are here

Article Text

Article menu
Download PDFPDF
Letters
Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

https://doi.org/10.1136/annrheumdis-2012-202088

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors IM: participated in data acquisition, analysis and interpretation; drafting, revision and final approval of the manuscript; CH: participated in data acquisition; drafting, revision and final approval of the manuscript; AK: participated in data acquisition; drafting, revision and final approval of the manuscript; EH participated in study conception, design and supervision; data analysis and interpretation; drafting, revision and final approval of the report; DV: participated in study conception, design and supervision; data acquisition, analysis and interpretation; and drafting, revision and final approval of the report.

    • Funding This research is funded by the Hellenic Society for Rheumatology, Special Account for Research Grants (SARG), National and Kapodistrian University of Athens, Athens, Greece.

    • Competing interests None.

    • Ethics approval Institutional Review Board.

    • Provenance and peer review Not commissioned; externally peer reviewed.